[HTML][HTML] Individualizing systemic therapies in first line treatment and beyond for advanced renal cell carcinoma
Y Khan, TD Slattery, LM Pickering - Cancers, 2020 - mdpi.com
Simple Summary In recent years, a number of new, effective treatments have become
available for advanced renal (kidney) cancer. However, with more drugs available it has …
available for advanced renal (kidney) cancer. However, with more drugs available it has …
[HTML][HTML] The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database
H Wei, J Miao, J Cui, W Zheng, X Chen, Q Zhang… - Scientific Reports, 2021 - nature.com
Existing data on the prognosis and clinicopathological features of patients with metastatic
renal cell carcinoma (mRCC) are limited. This study aims to investigate the prognostic value …
renal cell carcinoma (mRCC) are limited. This study aims to investigate the prognostic value …
[HTML][HTML] The impact of COVID-19 on new kidney cancer diagnosis: stage and treatment in Northern Italy
L Mangone, F Marinelli, G Bonfante, I Bisceglia… - International Journal of …, 2023 - mdpi.com
This study aims to evaluate the impact of COVID-19 on new renal carcinoma (RC)
diagnoses using data from the Reggio Emilia Cancer Registry in 2018–2020. A total of 293 …
diagnoses using data from the Reggio Emilia Cancer Registry in 2018–2020. A total of 293 …
[HTML][HTML] Early clinical experience with cabozantinib for advanced renal cell carcinoma in the UK: real-world treatment pathways and clinical outcomes
B Venugopal, M Pillai, T Powles, P Savage… - Clinical genitourinary …, 2022 - Elsevier
Background Cabozantinib monotherapy is approved in the UK for patients with treatment-
naïve intermediate-or poor-risk advanced renal cell carcinoma (aRCC), or patients who …
naïve intermediate-or poor-risk advanced renal cell carcinoma (aRCC), or patients who …
Patterns of first-line targeted therapy utilization and adherence among older adults diagnosed with metastatic renal cell carcinoma
Background Despite the rapid approval of targeted therapies for metastatic renal cell
carcinoma (mRCC) evidence on real world treatment patterns remains limited. This study …
carcinoma (mRCC) evidence on real world treatment patterns remains limited. This study …
Overview of clinical management for older patients with renal cell carcinoma
K Numakura, Y Nakai, T Kojima… - Japanese Journal of …, 2022 - academic.oup.com
The rapidly increasing pool of older patients being diagnosed with and surviving their
cancer is creating many challenges. Regarding localized renal cell carcinoma, surgery is …
cancer is creating many challenges. Regarding localized renal cell carcinoma, surgery is …
[图书][B] Three Essays in Health Economics: Understanding the Effects of Health Policies and Insurance Coverage on Cancer Outcomes
LM Tran - 2022 - search.proquest.com
As the second leading cause of death and major contributor to the rise in health
expenditures, cancer is a critical piece of US health care. My dissertation seeks to …
expenditures, cancer is a critical piece of US health care. My dissertation seeks to …